Executive Health Analytics · Healthcare Performance Intelligence

Executive Health Analytics Beyond the Annual Assessment

Connect each assessment to the years before and the follow-up after, so a premium programme delivers continuity rather than another static report.

See What Vizier Finds in Your Data

Bring the data you already collect. Keep the systems that produce it.

The buyer problem

More data has made interpretation harder for executive-health programme directors and clinical leaders.

Executive assessments assemble broad data at one moment, but the value is lost when results, recommendations and follow-up are not carried into a longitudinal analytical record.

The answer is not another isolated dashboard. It is a governed way to evaluate change across time and modalities, preserve what each source can and cannot establish, and make the underlying evidence available for review.

Where interpretation breaks

  • Annual reports are difficult to compare
  • Recommendations lack closed-loop tracking
  • Imaging and laboratory findings remain separate
  • Programme leaders cannot see cohort-level follow-up quality

Data landscape

The signals involved

The job is not to force unlike data into one score. It is to preserve provenance, time, context and uncertainty while making the relationships investigable.

Assessment results

Laboratory, physical, functional and validated questionnaire outputs.

Imaging conclusions

Structured findings and recommended follow-up from source systems.

Longitudinal history

Prior assessments, conditions, medications and later observations.

Follow-up

Referrals, actions, completion and subsequent measures.

The intelligence layer

What Vizier adds

Year-over-year change

Surface material movement instead of asking clinicians to compare reports manually.

Recommendation closure

Track whether high-priority follow-up occurred and what was observed later.

Cross-domain context

Review imaging, biomarker and functional signals together.

Programme quality

Measure completeness and variation without exposing individual data in analytics.

Interpretation discipline

Evidence before certainty

Vizier should make complex data easier to investigate without making the evidence stronger than it is. A temporal relationship is not automatically causal. A genetic association is not a diagnosis. Movement in a surrogate biomarker is not necessarily a clinical outcome.

Findings should retain source, timing, reference context and confidence. Where modalities disagree, data is missing, or follow-up is too short, the useful answer is often that the evidence is insufficient.

The distinctions that matter

  • Association is not causality; timing and confounding still matter.
  • Genetic predisposition is not the same as expressed phenotype.
  • Biomarker movement is not automatically a clinical outcome.
  • A biological-age estimate is model output, not a lifespan prediction.

Clear product boundary

What Vizier does—and does not—replace

Vizier does not run executive-health scheduling, concierge coordination or the clinical encounter. It analyses the programme's governed outputs.

Vizier consumes authorised outputs from the systems you choose. Source access, format, identity matching, governance, hosting and clinical review responsibilities are confirmed during discovery.

Vizier is not

  • A sequencing or FASTQ/BAM/VCF processing pipeline
  • A laboratory, EHR, scheduling, billing or CRM system
  • A diagnostic device or autonomous clinical decision-maker
  • A claim that an intervention caused a later change

Workflow

From fragmented outputs to a reviewable investigation

01

Inventory authorised sources, identifiers, time semantics and decision questions.

02

Validate units, mappings, provenance, missingness and clinically relevant comparison periods.

03

Configure longitudinal and cross-signal investigations around the organisation's reviewed definitions.

04

Return findings with evidence, uncertainty and a traceable path back to source data.

Questions buyers ask

Frequently asked questions

What is executive health analytics?

Executive Health Analytics is the governed analysis of relevant health data for longitudinal and cross-signal questions. For Vizier, that means analysing authorised outputs while retaining provenance, time and uncertainty.

Does Vizier replace our existing clinical or diagnostic systems?

Vizier does not run executive-health scheduling, concierge coordination or the clinical encounter. It analyses the programme's governed outputs.

Can Vizier prove that an intervention caused a change?

Not from timing alone. Vizier can align observations to an intervention, show competing explanations and describe the strength of evidence. Causal claims require an appropriate design and expert review.

How does implementation start?

With one decision question and a source inventory. Vizier validates access, identifiers, units, time semantics, governance and the review workflow before a capability is represented as production-ready.

Precision health intelligence

See executive health analytics across the data you already collect.

Bring the data you already collect. See what Vizier finds across it.

Start with the data you already have. Connect your EHR when you’re ready.